Concepedia

B Radha Krishnan

BR

Statistics

Publications

4

Citations

276

H-Index

4

Active since

2016

Affiliations

Cidara Therapeutics (United States)(Current)

B Radha Krishnan is an author at Cidara Therapeutics (United States) specializing in antifungal therapy, bioavailability, and antifungal agents.

Publications per year

2016–2021

4

Publications

4

Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin

Voon Ong, Grayson Hough, Michael Schlosser et al. · Antimicrobial Agents and Chemotherapy · 2016 · 123 citations · Full text

, , +17

CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility

B Radha Krishnan, Kenneth D. James, Karen Polowy et al. · The Journal of Antibiotics · 2016 · 90 citations · Full text

, , +17

Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species

Voon Ong, Kenneth D. James, Steven M. Smith et al. · Antimicrobial Agents and Chemotherapy · 2017 · 50 citations · Full text

, , +17

Larazotide acetate induces recovery of ischemia-injured porcine jejunum via repair of tight junctions

Zachary M. Slifer, Liliana Hernández, Tiffany Pridgen et al. · PLoS ONE · 2021 · 13 citations · Full text

, , +17

1–4 of 4